HKD 0.48
(9.2%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 52.04 Million | 1.39 Million | 48.83 Million | 145.14 Million | -29.25 Million | -8.7 Million |
Net Income | -50.68 Million | -23.63 Million | 2.68 Million | 21.42 Million | 52.85 Million | 53.5 Million |
Depreciation & Amortization | 56.2 Million | 52.71 Million | 29.26 Million | 23.87 Million | 19.99 Million | 17.16 Million |
Deferred income taxes | - | 21.45 Million | -89.41 Million | -2.85 Million | - | - |
Stock-based compensation | 782 Thousand | 2.35 Million | 3.07 Million | 1.21 Million | - | - |
Change in working capital | 27.51 Million | -23.81 Million | 86.34 Million | 1.64 Million | -102.38 Million | -73.22 Million |
Other non-cash items | 9.8 Million | -27.68 Million | 16.89 Million | 99.84 Million | 279 Thousand | -6.14 Million |
Investing Cash Flow | -42.45 Million | -55.08 Million | -51.35 Million | -19.94 Million | -32.33 Million | -21.81 Million |
Investments in PPE | -59.23 Million | -73.11 Million | -66.15 Million | -25.08 Million | -43.21 Million | -41.98 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 1.28 Million | 18.02 Million | 14.8 Million | 5.14 Million | 10.88 Million | 20.17 Million |
Financing Cash Flow | -31.23 Million | 70.75 Million | 28.09 Million | -115.18 Million | 41.71 Million | 9.44 Million |
Debt repayment | -16.14 Million | -631.59 Million | -441.23 Million | -519.15 Million | -235.91 Million | -109.2 Million |
Dividends payments | - | - | -6.67 Million | -2.22 Million | -19.08 Million | -60.13 Million |
Common Stock Repurchased | - | - | 439.17 Million | - | 331.67 Million | - |
Common Stock Issuance | - | - | 2.06 Million | - | 121.89 Million | - |
Other Financing Activities | -19.15 Million | 702.35 Million | 34.76 Million | 406.19 Million | -156.86 Million | 178.78 Million |
Accounts receivables | 13.04 Million | -5.62 Million | 3.04 Million | -6.37 Million | -3.71 Million | -1.55 Million |
Accounts payables | - | -28.28 Million | 10.6 Million | -41.77 Million | 3.71 Million | 1.55 Million |
Inventory | -58.34 Million | -18.19 Million | 83.29 Million | 8.01 Million | -67.06 Million | -72.24 Million |
Other working capital | 59.44 Million | 28.28 Million | -10.6 Million | 41.77 Million | -35.32 Million | -975 Thousand |
Cash at beginning of period | 82.22 Million | 65.02 Million | 39.39 Million | 28.96 Million | 50.04 Million | 71.11 Million |
Cash at end of period | 60.59 Million | 82.22 Million | 65.02 Million | 39.39 Million | 28.96 Million | 50.04 Million |
Capital Expenditure | -59.23 Million | -73.11 Million | -66.15 Million | -25.08 Million | -43.21 Million | -41.98 Million |
Effect of forex changes on cash | 8000.00 | 135 Thousand | 57 Thousand | 408 Thousand | -1.19 Million | - |
Net cash flow / Change in cash | -21.63 Million | 17.2 Million | 25.63 Million | 10.42 Million | -21.08 Million | -21.07 Million |
Free Cash Flow | -7.19 Million | -71.71 Million | -17.32 Million | 120.05 Million | -72.47 Million | -50.68 Million |
Breakdown | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -24.75 Million | -50.68 Million | -27.6 Million | -23.63 Million | -16.39 Million | -7.23 Million |
Depreciation & Amortization | 26.83 Million | 56.2 Million | 29.32 Million | 52.71 Million | 29.91 Million | 22.8 Million |
Deferred income taxes | - | - | 66.06 Million | 21.45 Million | -71.13 Million | 92.59 Million |
Stock-based compensation | 208 Thousand | 782 Thousand | 574 Thousand | 2.35 Million | 796 Thousand | 1.56 Million |
Change in working capital | 24.85 Million | 27.51 Million | -10.71 Million | -23.81 Million | 50.95 Million | -46.48 Million |
Other non-cash items | 50.08 Million | 9.8 Million | -16.75 Million | -27.68 Million | -6.35 Million | -28.15 Million |
Investing Cash Flow | -23.36 Million | -42.45 Million | -19.09 Million | -55.08 Million | -25.58 Million | -29.5 Million |
Investments in PPE | -29.67 Million | -59.23 Million | -28.84 Million | -73.11 Million | -38.19 Million | -34.91 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 6.31 Million | 1.28 Million | 9.74 Million | 18.02 Million | 12.61 Million | 5.41 Million |
Financing Cash Flow | -21.57 Million | -31.23 Million | -9.66 Million | 70.75 Million | 5.13 Million | 65.62 Million |
Debt repayment | - | -16.14 Million | -6.59 Million | -631.59 Million | - | -59.2 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -21.57 Million | -19.15 Million | -3.07 Million | 702.35 Million | 5.13 Million | 124.82 Million |
Accounts receivables | 16.06 Million | 13.04 Million | -3.01 Million | -5.62 Million | -7.65 Million | 2.03 Million |
Accounts payables | - | - | - | -28.28 Million | - | - |
Inventory | 5.27 Million | -58.34 Million | -63.62 Million | -18.19 Million | 77.99 Million | -96.18 Million |
Other working capital | 3.51 Million | 59.44 Million | 55.92 Million | 28.28 Million | -19.39 Million | 47.67 Million |
Cash at beginning of period | 28.28 Million | 82.22 Million | 82.22 Million | 65.02 Million | 43.63 Million | 65.02 Million |
Cash at end of period | 28.28 Million | 60.59 Million | 28.28 Million | 82.22 Million | 82.22 Million | 43.63 Million |
Capital Expenditure | -29.67 Million | -59.23 Million | -28.84 Million | -73.11 Million | -38.19 Million | -34.91 Million |
Effect of forex changes on cash | 15 Thousand | 8000.00 | -7000.00 | 135 Thousand | 129 Thousand | 6000.00 |
Net cash flow / Change in cash | - | -21.63 Million | -53.94 Million | 17.2 Million | 38.59 Million | -21.39 Million |
Free Cash Flow | 47.55 Million | -7.19 Million | -54.02 Million | -71.71 Million | 20.71 Million | -92.43 Million |
SEDG
CPRT
DLYT
1834
ADANIENSOL
RVSNW